Mesenchymal stromal cells promote the formation of lung cancer organoids via Kindlin-2

Abstract excerpt

BACKGROUND: Patient-derived lung cancer organoids (PD-LCOs) demonstrate exceptional potential in preclinical testing and serve as a promising model for the multimodal management of lung cancer. However, certain lung cancer cells derived from patients exhibit limited capacity to generate organoids due to inter-tumor or intra-tumor variability. To overcome this limitation, we have created an in vitro system that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Cells and Metastasis
• Share to Mesenchymal stem cell research
• Share to Tissue Engineering and Regenerative Medicine